Dr Juan Manuel O’Connor

Go Back

Medical Oncologist

  • Instituto Alexander Fleming
  • location Argentina

Dr Juan Manuel O’Connor is currently Head of the Department of Gastrointestinal Tumors at Instituto Alexander Fleming, a position he has held since 2015. He is Assistant Professor of Clinical Pharmacology at the School of Medicine of the Instituto Universitario CEMIC, Buenos Aires. He is a founding member of the Argentine Group of Neuroendocrine Tumors (ARGENTUM), created in 2005. Dr O´Connor is a member of the Argentinian Intergroup of Gastrointestinal Tumors (IATTGI), and also of the recently created Latin American Society for Gastrointestinal Tumors, chaired by Dr Jorge Gallardo. He has been a member of the Advisory Board of the European Society of Neuroendocrine Tumors, ENETS since 2008, and an active member of ASCO since 2011. He finished his fellowship in Clinical Oncology in 2003, held at the Alexander Fleming Institute, affiliated to the University of Buenos Aires, rating with Cum Laude10/10. Dr O´Connor has authored over 50 papers and chapters of books about gastrointestinal tumors. He received several international awards for his work in the area of ​​neuroendocrine tumors. He has participated in more than 200 national and international events as a speaker. Dr O´Connor also served as a consultant to the National Cancer Institute in Argentina, and was involved in the development of the Clinical Practice Guidelines in Metastatic Colorectal Cancer in Argentina, in 2014.

Dr Juan Manuel O’Connor has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Merck, MSD, BMS, Servier, Ipsen, Sanofi, Pfizer

Programmes developed by Dr Juan Manuel O’Connor

Oncology 
Optimising treatment sequencing for mCRC, third line and beyond

Clinical topic video update

Experts
Prof. Sebastian Stintzing, Dr Juan Manuel O'Connor
  • download Downloadable
    Resources
  • clock 9 MIN
  • calendar Jan 2023

Educational programme supported by an Independent Medical Education grant from Bayer